Want to see PRAX full AI Analyst Report?

Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

1,011 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PRAX Analyst Ratings

Strong Buy

16 Buy

1 Hold

1 Sell

Based on 18 analysts giving stock ratings to

Praxis

Precision Medicines

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PRAX Stock 12 Month Forecast

Average Price Target

$604.71

▲(76.56% Upside)

Based on 18 Wall Street analysts offering 12 month price targets for Praxis Precision Medicines in the last 3 months. The average price target is $604.71 with a high forecast of $1,201.00 and a low forecast of $162.00. The average price target represents a 76.56% change from the last price of $342.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"42":"$42","332":"$332","622":"$622","912":"$912","1202":"$1,202"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1201,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":604.7058823529412,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$604.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":162,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$162.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[42,332,622,912,1202],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,319.6,387.40000000000003,455.20000000000005,523,590.8,658.6,726.4,794.2,862,929.8,997.6,1065.4,1133.1999999999998,{"y":1201,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,319.6,341.53122171945705,363.4624434389141,385.39366515837105,407.3248868778281,429.2561085972851,451.1873303167421,473.1185520361991,495.04977375565613,516.9809954751131,538.9122171945702,560.8434389140272,582.7746606334842,{"y":604.7058823529412,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,319.6,307.4769230769231,295.3538461538462,283.2307692307692,271.10769230769233,258.9846153846154,246.8615384615385,234.73846153846154,222.61538461538464,210.4923076923077,198.3692307692308,186.24615384615385,174.12307692307692,{"y":162,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":43.17,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.94,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":309.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":324.2,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":335.16,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,201

Average Price Target$604.71

Lowest Price Target$162.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Yatin Suneja

Guggenheim

$800

Buy

133.58%

Upside

Reiterated

06/30/26

Praxis Precision Medicines (PRAX) Receives a Buy from Guggenheim

Yasmeen Rahimi

Piper Sandler

$1,200

Buy

250.36%

Upside

Reiterated

06/30/26

Analysts Are Bullish on Top Healthcare Stocks: Definium Therapeutics (DFTX), Atricure (ATRC)

Andrew Tsai

Jefferies

$550

Buy

60.58%

Upside

Reiterated

06/30/26

Jefferies Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

Tiago Fauth

Raymond James

―

Buy

―

Reiterated

06/30/26

Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Aurora Cannabis (ACB)

Francois Brisebois

LifeSci Capital

$731→$719

Buy

109.93%

Upside

Reiterated

06/30/26

Raymond James Analyst Maintains Buy on Praxis, Sees PDUFA Extension as Manageable While Trimming Price Target from $731 to $719

Benjamin Burnett

Wells Fargo

$323

Hold

-5.69%

Downside

Assigned

06/30/26

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and Boston Scientific (NYSE: BSX)

Ritu Baral

TD Cowen

$510

Buy

48.91%

Upside

Reiterated

06/29/26

Praxis Precision Medicines (PRAX) Receives a Buy from TD Cowen

Ami Fadia

Needham

$537→$575

Buy

67.88%

Upside

Assigned

06/29/26

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY), Biohaven Ltd. (NYSE: BHVN) and Praxis Precision Medicines (NASDAQ: PRAX)

Kambiz Yazdi

BTIG

$810

Buy

136.50%

Upside

Reiterated

06/29/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Outlook Therapeutics (NASDAQ: OTLK), Praxis Precision Medicines (NASDAQ: PRAX) and Merck & Company (NYSE: MRK)

Leonid Timashev

RBC Capital

$449

Buy

31.09%

Upside

Initiated

06/17/26

Praxis Precision initiated with an Outperform at RBC CapitalPraxis Precision initiated with an Outperform at RBC Capital

Douglas Tsao

H.C. Wainwright

$1,245→$1,201

Buy

250.66%

Upside

Reiterated

06/08/26

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) and Cullinan Management (NASDAQ: CGEM)

Jay Olson

Oppenheimer

$750→$650

Buy

89.78%

Upside

Assigned

06/02/26

Praxis Precision price target lowered to $650 from $750 at OppenheimerPraxis Precision price target lowered to $650 from $750 at Oppenheimer

Danielle Brill

Truist Financial

$715→$616

Buy

79.85%

Upside

Assigned

06/02/26

Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial

Laura Chico

Wedbush

$166→$162

Sell

-52.70%

Downside

Reiterated

06/02/26

Praxis Precision price target lowered to $162 from $166 at WedbushPraxis Precision price target lowered to $162 from $166 at Wedbush

David Hoang

Deutsche Bank

$420→$374

Buy

9.20%

Upside

Reiterated

06/02/26

Praxis Precision price target lowered to $374 from $420 at Deutsche BankPraxis Precision price target lowered to $374 from $420 at Deutsche Bank

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Yatin Suneja

Guggenheim

$800

Buy

133.58%

Upside

Reiterated

06/30/26

Praxis Precision Medicines (PRAX) Receives a Buy from Guggenheim

Yasmeen Rahimi

Piper Sandler

$1,200

Buy

250.36%

Upside

Reiterated

06/30/26

Analysts Are Bullish on Top Healthcare Stocks: Definium Therapeutics (DFTX), Atricure (ATRC)

Andrew Tsai

Jefferies

$550

Buy

60.58%

Upside

Reiterated

06/30/26

Jefferies Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

Tiago Fauth

Raymond James

―

Buy

―

Reiterated

06/30/26

Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Aurora Cannabis (ACB)

Francois Brisebois

LifeSci Capital

$731→$719

Buy

109.93%

Upside

Reiterated

06/30/26

Raymond James Analyst Maintains Buy on Praxis, Sees PDUFA Extension as Manageable While Trimming Price Target from $731 to $719

Benjamin Burnett

Wells Fargo

$323

Hold

-5.69%

Downside

Assigned

06/30/26

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and Boston Scientific (NYSE: BSX)

Ritu Baral

TD Cowen

$510

Buy

48.91%

Upside

Reiterated

06/29/26

Praxis Precision Medicines (PRAX) Receives a Buy from TD Cowen

Ami Fadia

Needham

$537→$575

Buy

67.88%

Upside

Assigned

06/29/26

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY), Biohaven Ltd. (NYSE: BHVN) and Praxis Precision Medicines (NASDAQ: PRAX)

Kambiz Yazdi

BTIG

$810

Buy

136.50%

Upside

Reiterated

06/29/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Outlook Therapeutics (NASDAQ: OTLK), Praxis Precision Medicines (NASDAQ: PRAX) and Merck & Company (NYSE: MRK)

Leonid Timashev

RBC Capital

$449

Buy

31.09%

Upside

Initiated

06/17/26

Praxis Precision initiated with an Outperform at RBC CapitalPraxis Precision initiated with an Outperform at RBC Capital

Douglas Tsao

H.C. Wainwright

$1,245→$1,201

Buy

250.66%

Upside

Reiterated

06/08/26

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) and Cullinan Management (NASDAQ: CGEM)

Jay Olson

Oppenheimer

$750→$650

Buy

89.78%

Upside

Assigned

06/02/26

Praxis Precision price target lowered to $650 from $750 at OppenheimerPraxis Precision price target lowered to $650 from $750 at Oppenheimer

Danielle Brill

Truist Financial

$715→$616

Buy

79.85%

Upside

Assigned

06/02/26

Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial

Laura Chico

Wedbush

$166→$162

Sell

-52.70%

Downside

Reiterated

06/02/26

Praxis Precision price target lowered to $162 from $166 at WedbushPraxis Precision price target lowered to $162 from $166 at Wedbush

David Hoang

Deutsche Bank

$420→$374

Buy

9.20%

Upside

Reiterated

06/02/26

Praxis Precision price target lowered to $374 from $420 at Deutsche BankPraxis Precision price target lowered to $374 from $420 at Deutsche Bank

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Praxis Precision Medicines

3 Months

Yatin SunejaGuggenheim

Success Rate

13/13 ratings generated profit

Average Return

+48.30%

Copying Yatin Suneja's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +48.30% per trade.

1 Year

Yatin SunejaGuggenheim

Success Rate

12/13 ratings generated profit

Average Return

+191.38%

Copying Yatin Suneja's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +191.38% per trade.

2 Years

Douglas TsaoH.C. Wainwright

Success Rate

28/28 ratings generated profit

Average Return

+386.61%

Copying Douglas Tsao's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +386.61% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRAX Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PRAX has received 38 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. PRAX average Analyst price target in the past 3 months is 604.71.

Each month's total comprises the sum of three months' worth of ratings.

PRAX Financial Forecast

PRAX Earnings Forecast

Next quarter’s earnings estimate for PRAX is -$3.67 with a range of -$5.33 to -$3.04. The previous quarter’s EPS was -$3.20. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Sales Forecast

Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Stock Forecast FAQ

What is PRAX’s average 12-month price target, according to analysts?

Based on analyst ratings, Praxis Precision Medicines, Inc.’s 12-month average price target is 604.71.

What is PRAX’s upside potential, based on the analysts’ average price target?

Praxis Precision Medicines, Inc. has 76.56% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PRAX a Buy, Sell or Hold?

Praxis Precision Medicines, Inc. has a consensus rating of Strong Buy which is based on 16 buy ratings, 1 hold ratings and 1 sell ratings.

What is Praxis Precision Medicines, Inc.’s price target?

The average price target for Praxis Precision Medicines, Inc. is 604.71. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,201.00 ,the lowest forecast is $162.00. The average price target represents 76.56% Increase from the current price of $342.5.

What do analysts say about Praxis Precision Medicines, Inc.?

Praxis Precision Medicines, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.

How can I buy shares of PRAX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

PRAX Analyst Ratings

PRAX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Praxis Precision Medicines

PRAX Analyst Recommendation Trends

PRAX Financial Forecast

PRAX Earnings Forecast

PRAX Sales Forecast

PRAX Stock Forecast FAQ

Detailed List of Analyst Forecasts